Altered pattern of cytokine production by peripheral blood CD2+ cells from B chronic lymphocytic leukemia patients
- 1 February 1998
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 57 (2) , 93-100
- https://doi.org/10.1002/(sici)1096-8652(199802)57:2<93::aid-ajh1>3.0.co;2-w
Abstract
To determine if activation-induced cytokine production is altered in CD2+ lymphocytes from B-CLL patients, cytokine levels were determined by ELISA in supernatants of PHA-stimulated cultures of CD2+ cells from 33 B-CLL patients and 22 healthy controls. The production of Interferon γ (IFN-γ) and Tumor Necrosis Factor (TNF-α) by mitogen-activated CD2+ lymphocytes from B-CLL patients was higher than that found in healthy controls, while no differences were found in TNF-β production. IFN-γ and TNF-α levels determined at 72 h in PHA-stimulated CD2+ cell cultures from B-CLL patients statistically correlated with the percentages of CD3+CD45RO+ and CD3−CD56+ lymphocytes, respectively. Although there were differences in the production kinetics of interleukins (ILs) 2 and 4 between B-CLL patients and the healthy controls, no differences were found at the time when the levels of both interleukins peak. The production of both IFN-γ and IL-4 by PHA-stimulated CD2+ lymphocytes from non-smouldering B-CLL patients was significantly higher than that from smouldering B-CLL patients while no significant differences were found in the production of IL-2, TNF-α, and TNF-β between the two B-CLL patient groups. These data suggest that functional alterations in the production of cytokines by CD2+ cells from B-CLL patients could help to explain the expansion of leukemic cells in B-CLL patients. Am. J. Hematol. 57:93–100, 1998.Keywords
This publication has 40 references indexed in Scilit:
- Clinicopathological and immunophenotypic studies on 12 cases with B cell chronic lymphocytic leukemiaPathology International, 1994
- Interleukin‐4 inhibits apoptotic cell death and loss of the bcl‐2 protein in B‐chronic lymphocytic leukaemia cells in vitroBritish Journal of Haematology, 1993
- Heterogeneous proliferative effect of tumor necrosis factor-α and lymphotoxin on mitogen-activated B cells from B-chronic lymphocytic leukemiaAmerican Journal of Hematology, 1993
- Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia.The Journal of Experimental Medicine, 1993
- Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression.The Journal of Experimental Medicine, 1992
- INCREASED PERCENTAGE OF ACTIVATED T LYMPHOCYTES IN B CELL LYMPHOCYTIC LEUKAEMIA (B-CLL) PATIENTSBritish Journal of Haematology, 1991
- Production of Interferon by Peripheral Blood Mononuclear Cells from Normal Individuals and Patients with Chronic Lymphocytic LeukemiaJournal of Interferon Research, 1986
- T lymphocytes in B-cell chronic lymphocytic leukemia: Characterization by monoclonal antibodies and correlation with Fc receptorsClinical Immunology and Immunopathology, 1983
- Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia.The Journal of Experimental Medicine, 1982
- Factors influencing the duration of survival of patients with chronic lymphocytic leukemiaThe American Journal of Medicine, 1966